The Archer® VariantPlex® Solid Tumor Kit is a targeted sequencing assay that simultaneously detects and characterizes single nucleotide variants (SNVs), copy number variations (CNVs) and insertions and deletions (indels) in 67 genes associated with solid tumors. Apart from the Variantplex kit, ArcherDx has thorough product line of NGS Solid Tumor assays to detect various driver mutation types. This approach combines FusionPlex®, VariantPlex® and Reveal ctDNA™ kits to characterize gene fusions, expression, CNVs and other variants from a single, low-input FFPE sample and liquid biopsy.
Solid Tumor
ABL1 (ABL proto-oncogene 1), AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), AURKA (Aurora kinase A)
See More ...
Next-Generation Sequencing (NGS)